Roche drug fails in early-onset Alzheimer's disease study

Roche's experimental drug gantenerumab failed to slow cognitive decline in people with a rare inherited form of Alzheimer's disease, the latest setback for companies hunting for a cure for the devastating brain-wasting disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news